LYNKEUS

Their core work

LYNKEUS is a Rome-based SME specializing in the ethical, legal, and data governance dimensions of health data sharing and digital platforms. They design frameworks for data interoperability, privacy-preserving technologies, and regulatory compliance — particularly in cardiovascular and cancer imaging research. Their work sits at the intersection of legal expertise and technical infrastructure, helping consortia navigate FAIR data principles, blockchain-based identity, and AI governance in clinical settings.

What they specialise in

How they've shifted over time

LYNKEUS started with broader digital platform work (dance education in WhoLoDancE, 2016) and personal health data ownership (MH-MD, 2016), establishing themselves as a data governance SME. From 2018 onward, they narrowed sharply into health-specific data sharing — first cardiovascular (euCanSHare), then personal data markets (KRAKEN), then cancer imaging (EuCanImage) and in-silico medical device testing (SIMCOR). The clear trajectory is from general data platforms toward specialized health data governance with increasing emphasis on AI regulation and virtual clinical trials.

LYNKEUS is moving toward AI and in-silico regulatory frameworks in healthcare, positioning them well for projects needing ethical AI deployment and virtual clinical trial compliance under evolving EU regulations.

How they like to work

LYNKEUS splits evenly between leading and joining: they coordinated 2 projects (the earlier, smaller ones) and participated in 4 larger consortia. With 74 unique partners across 19 countries, they maintain a broad European network rather than relying on repeat collaborators. This profile suggests a flexible partner that can take ownership of governance work packages in large consortia or lead focused projects when the scope matches their specialization.

LYNKEUS has built a wide network of 74 partners spanning 19 countries, indicating strong pan-European reach. Their consortia tend to be large health-data initiatives connecting hospitals, universities, and tech companies across the EU and Canada.

What sets them apart

LYNKEUS occupies a rare niche: an SME that combines legal/ethical expertise with technical data platform knowledge, specifically for health research. Most legal advisors in EU projects lack technical depth, and most tech partners lack regulatory insight — LYNKEUS bridges both. For consortium builders needing a partner to handle GDPR compliance, FAIR data governance, or AI ethics work packages in health projects, they are a proven and experienced choice from Italy.

Highlights from their portfolio

• EuCanImage
  Their largest funded project (EUR 679,500), addressing AI governance in cancer imaging with concepts like 'AI passport' — directly relevant to the EU AI Act.
• euCanSHare
  A major EU-Canada joint infrastructure project for cardiovascular research, demonstrating LYNKEUS's ability to contribute to large-scale international health data platforms.
• KRAKEN
  Focused on personal data brokerage using blockchain and decentralised identity — showing their work extends beyond health into broader data economy governance.